Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9708406 Anti-transferrin receptor antibodies and methods of use

Patent 9708406 was granted and assigned to Genentech on July, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Yin Zhang0

Gregory A. Lazar0

James A. Ernst0

Jasvinder Atwal0

Jessica Couch0

Joy Yu Zuchero0

Mark S. Dennis0

Ryan J. Watts0

Date of Patent

July 18, 2017

Patent Application Number

14283038

Date Filed

May 20, 2014

Patent Citations Received

0

US Patent 12071485 Compositions and methods of treating facioscapulohumeral muscular dystrophy

0

US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy

0

US Patent 11672872 Anti-transferrin receptor antibody and uses thereof

0

US Patent 11679161 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

0

US Patent 11759525 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

US Patent 12128109 Muscle targeting complexes and formulations for treating dystrophinopathies

0

US Patent 12102687 Muscle targeting complexes and uses thereof for treating myotonic dystrophy

0

...

Patent Primary Examiner

Michael Szperka

Patent abstract

The present invention relates to anti-transferrin receptor antibodies and methods of their use.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9708406 Anti-transferrin receptor antibodies and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool